Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1159 of 1,261
  1. US 6696585

    Functionalized nanoparticles

    The Board of Regents of the University of Texas System · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  2. US 6696459

    Steroid receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  3. US 6696500

    Sustained-release preparation

    Takeda Chemical Industries Ltd. · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  4. US 6696407

    Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF

    The Regents of the University of California · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  5. US 6696601

    Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  6. US 6696441

    Inhibition of p53-induced stress response

    The Regents of the University of California · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  7. US 6696263

    PCNA associated cell cycle proteins, compositions and methods of use

    Rigel Pharmaceuticals, Inc. · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  8. US 6696079

    Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II) complexes

    The Board of Regents of the University of Texas System · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  9. US 6696064

    Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  10. US 6696559

    Antimicrobial peptides and methods of use

    The Regents of the University of California · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  11. US 6696562

    Avian astrovirus

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  12. US 6696600

    L-DOPA ethyl ester salts and uses thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  13. US 6696089

    Nanogel networks including polyion polymer fragments and biological agent compositions thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  14. US 6696452

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  15. US 6696242

    Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 24, 2004 · Expires Feb 19, 2024

    expired
  16. US 2004033243

    SINCALIDE FORMULATIONS

    BRACCO INT BV [NL] · Granted Feb 19, 2004 · Expires Feb 14, 2024

    expired
  17. US 6693075

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  18. US 6692910

    Inhibition of a target messenger RNA with a modified U1 small nuclear RNA

    UNIVERSITY OF CONNECTICUT · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  19. US 6692763

    Methods for treating postmenopausal women using ultra-low doses of estrogen

    The Regents of the University of California · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  20. US 6692750

    Alphavirus expression vector

    Bioption AB · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  21. US 6692759

    Methods for preparing and using implantable substance delivery devices

    The Regents of the University of California · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  22. US 6692964

    Methods for transfecting T cells

    United States of America as represented by the Secretary of the Air Force · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  23. US 6692741

    Treatment of acute lung injury and fibrosis with antagonists of &bgr;6-specific antibodies

    The Regents of the University of California · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired
  24. US 6692724

    Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.